OKYO
NASDAQ
GB
OKYO Pharma Limited - Ordinary Shares
$1.68
▲ +$0.02
(+1.20%)
Vol 72K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$77.9M
ROE
-134.5%
D/E
0.00
Beta
-0.01
52W
$1–$3
Wall Street Consensus
10 analysts · Apr 20262
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2025-03-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -134.5% | -134.5% | -134.5% | -134.5% | -134.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 |
Key Ratios
ROA (TTM)
-144.7%
P/B
38.9
EPS (TTM)
$-0.12
CF/Share
$-28.73
52W High
$3.35
52W Low
$0.90
$0.90
52-Week Range
$3.35
How does OKYO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
OKYO valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
38.9
▲
1480%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
OKYO profitability vs Biotechnology peers
ROE
-134.5%
▼
100%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-144.7%
▼
210%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
OKYO financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
0.4
▼
91%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.0
▼
102%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
OKYO fundamentals radar
OKYO
Peer median
Industry
OKYO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio